[Blood coagulation, fibrinolysis and kallikreinogenesis in diabetics with vascular complications treated with insulin or sulfonylurea derivatives].
D001777:Blood Coagulation / Q000187:drug effects*; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000188:drug therapy*; D005260:Female; D005342:Fibrinolysis / Q000187:drug effects; D006801:Humans; D007328:Insulin / Q000494:pharmacology* / Q000627:therapeutic use; D007610:Kallikreins / Q000096:biosynthesis*; D008297:Male; D013453:Sulfonylurea Compounds / Q000494:pharmacology* / Q000627:therapeutic use; D014652:Vascular Diseases / Q000150:complications
D007328:Insulin; D013453:Sulfonylurea Compounds; D007610:Kallikreins
Krzepliwość krwi, fibrynoliza i kalikreinogeneza w angiopatii cukrzycowej leczonej insulina lub pochodnymi sulfonylomocznika.